Navigation Links
Heart disease may be a risk factor for prostate cancer
Date:2/8/2012

DURHAM, N.C. In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.

If confirmed that heart disease is a risk factor for prostate cancer, the malignancy might be combated in part by lifestyle changes such as weight loss, exercise and a healthy diet, which are known to prevent heart disease.

"What's good for the heart may be good for the prostate," said Jean-Alfred Thomas II, M.D., a post-doctoral fellow in the Division of Urology at Duke and lead author of the study, which appears online this month in the journal Cancer Epidemiology, Biomarkers & Prevention.

Coronary artery disease kills more adults in the United States than any other cause, accounting for one in four deaths. Risk factors include inactivity, obesity, high blood pressure and cholesterol, cigarette smoking, and diabetes.

Similarly, prostate cancer is a common killer. It's the second-most lethal cancer for U.S. men, behind lung cancer, with about 240,000 new cases diagnosed a year, and 34,000 deaths. Previous studies exploring the relationship between coronary artery disease and prostate cancer risk have found conflicting results, making it difficult to determine whether the malignancy is fueled by poor lifestyle choices.

In the current study, the Duke team used data from 6,390 men enrolled in a large study called REDUCE, a four-year, randomized trial to test the prostate cancer risk reduction benefits of a drug called dutasteride. All the study participants had a prostate biopsy at the two- and four-year marks, regardless of their PSA levels. They also provided a detailed medical history that included their weight, incidence of heart disease, alcohol intake, medication use and other factors.

Among the men in the study, 547 reported a pre-enrol
'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. ROCK off: Study establishes molecular link between genetic defect and heart malformation
2. Scientists make strides toward fixing infant hearts
3. The effect of occasional binge drinking on heart disease and mortality among moderate drinkers
4. Powering pacemakers with heartbeat vibrations
5. Study Finds Link Between Heart Failure, Brain Changes
6. The NIH urges women to protect their heart health
7. Heartburn Drugs May Raise Fracture Risk in Older Women
8. ACCF/AATS/SCAI/STS release consensus document to help guide use of minimally invasive heart therapy
9. 2-arm blood pressure check indicator for risk from heart disease or death
10. Optimal Heart Health Starts Early: Study
11. Rapid urbanization as well as cultural habits explain Gulf states rise in heart disease prevalence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... (PRWEB) December 20, 2014 Developers of ... release of a new plugin for Final Cut Pro ... , “TranSlice Volume 5 allows users to create hand ... it.” Said Christina Austin, CEO of Pixel Film Studios. ... of professionalism while maintaining an easy to use interface.” ...
(Date:12/20/2014)... December 20, 2014 Today, Balfleet.com, one ... a Christmas Sale, offering 50%-70% off on its ... season. , The mother of the bride dresses from ... company is 24/7 accessible and takes pride in providing ... , “We are offering great discounts on our mother ...
(Date:12/19/2014)... Sub Zero Ice Cream is partnering up with ... the 28th from 2pm-6pm at the Expo Center on the ... FL. , Inquiries regarding time slots and signing up, email ... donating process, Sub Zero Ice Cream & Yogurt will be ... , About Sub Zero Ice Cream & Yogurt , ...
(Date:12/19/2014)... CA (PRWEB) December 19, 2014 SuperCloset ... 5x5 SuperClone Rooms. SuperCloset continues to offer indoor growers ... Pair one of the new SuperClone Rooms with the ... perpetual, and turnkey indoor hydroponic grow room setup. , ... the world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... TX (PRWEB) December 20, 2014 The ... a new injectable filler from respected cosmetic brand Juvéderm. ... occur naturally with age. The Medspa at Hendrick is ... development in skin care technology to its clients. , ... gel to be FDA-approved to treat the mid-face and ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2
... Greater International Representation, WASHINGTON, Aug. 12 ... participation of 37 Supporting Partner,Organizations from around ... Zealand, Russia and the United Kingdom, as ... in the U.S. These Supporting Partner,Organizations have ...
... Investment Trust Inc.,(NYSE: CRE ) ("Care"), a real ... and commercial mortgage debt,today announced an agreement in principle ... terms:, -- Care will receive an option to ... mortgage assets on an individual basis at any time ...
... The development and repair of heart tissue and blood ... ribonucleic acid (RNA) that is found nowhere else in ... found. , Because of its specificity to the cardiovascular ... therapeutic treatment, the researchers said. , "Manipulating this microRNA ...
... N.J., Aug. 12 Barr Pharmaceuticals,Inc. (NYSE: ... Barr Laboratories subsidiary has,signed a Settlement Agreement ... resolve the patent litigation involving Boehringer Ingelheim,s,Mirapex(R) ... Settlement,Agreement and a Supply Agreement to resolve ...
... the release of Sfetyworks™, a web-based, semi-automated ... quickly spot and measure the strength of ... condition found within large electronic healthcare databases. ... plc (GSK) and ProSanos. Several years in ...
... Ind., Aug. 12 Hillenbrand, Inc.,(NYSE: HI ... consistent,with $165.6 million reported in the third quarter ... third-quarter earnings per share, operating,profit and cash flow ... for the quarter remained essentially flat, even as ...
Cached Medicine News:Health News:AdvaMed 2008 Supporting Partner Organizations Up 30% Over Last Year 2Health News:AdvaMed 2008 Supporting Partner Organizations Up 30% Over Last Year 3Health News:AdvaMed 2008 Supporting Partner Organizations Up 30% Over Last Year 4Health News:Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee 2Health News:Tiny molecule helps control blood-vessel development, UT Southwestern researchers find 2Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 2Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 3Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 4Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 5Health News: ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records 2Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 2Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 3Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 4Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 5Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 6Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 7Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 8Health News:Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42 9
(Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
(Date:12/17/2014)... , Alemania, December 17, 2014 ... año anterior, con un alto nivel de gasto en ... año fiscal 2013/14 (finalizado el 30 de septiembre de ... ciento a 4.287 millones de euros (año anterior: 4.190 ... la moneda desfavorables. Las ganancias (EBIT) crecieron un 14 ...
(Date:12/17/2014)... 17, 2014 With advancements in neurological ... market is seeing new growth, according to Kalorama ... account for the majority of market volume, newer ... images, which are creating opportunities for more sophisticated applications. ... growing at a rate of 4%, with world ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS confirma su posición en un entorno difícil 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... e-power series power supplies are ... gel electrophoresis system. These units ... the most rigorous safety standard, ... the most compact and powerful ...
... ZOOM® Dual Power is a microprocessor-controlled ... both high voltage/low current and high ... voltage/low current section is ideal for ... DNA sequencing applications. The low voltage/high ...
... These modified battery chargers ... supplies for GENIE blotters. ... produce very specific voltages, ... than laboratory power supplies. ...
... These modified battery ... power supplies for GENIE ... to produce very specific ... reproducibility than laboratory power ...
Medicine Products: